Adherence to raloxifene therapy: assessment methods and relationship with efficacy

By Finigan J.   Naylor K.   Paggiosi M.   Peel N.   Eastell R.  

Osteoporosis International, Vol. 24, Iss. 11, 2013-11 ,pp. : 2879-2886

Springer Publishing Company

Access to resources Recommend Favorite

Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy

By Cosman F.   Nieves J.   Zion M.   Barbuto N.   Lindsay R.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite

The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial

By Qu Yongming   Wong Mayme   Thiebaud Daniel   Stock John L.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1955-1959

Informa Healthcare

Access to resources Recommend Favorite

Hypocalcemia Induced by Raloxifene

By  

Current Drug Safety, Vol. 7, Iss. 2, 2012-04 ,pp. : 176-178

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term raloxifene for postmenopausal osteoporosis

By Recker Robert R.   Mitlak Bruce H.   Ni Xiao   Krege John H.  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite